Does VEDOLIZUMAB Cause Infusion site erythema? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Infusion site erythema have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.1% of all adverse event reports for VEDOLIZUMAB.
38
Reports of Infusion site erythema with VEDOLIZUMAB
0.1%
of all VEDOLIZUMAB reports
1
Deaths
13
Hospitalizations
How Dangerous Is Infusion site erythema From VEDOLIZUMAB?
Of the 38 reports, 1 (2.6%) resulted in death, 13 (34.2%) required hospitalization.
Is Infusion site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Infusion site erythema?
TREPROSTINIL (2,990)
HUMAN IMMUNOGLOBULIN G (1,850)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (312)
AMBRISENTAN (308)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (213)
FOSCARBIDOPA\FOSLEVODOPA (157)
MACITENTAN (147)
EPOPROSTENOL (90)
RIOCIGUAT (80)
LECITHIN\POLOXAMER 407 (70)
Which VEDOLIZUMAB Alternatives Have Lower Infusion site erythema Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB